The Competitive Advantage

Oncoprev™ Competitive Advantage

  • Selective Targeting Cancer Cells: Designed to target and selectively bind to cancerous cells, leaving healthy cells intact. This makes Oncoprev™ potentially the most unique and valuable cancer treatment today.
  • Reduced Toxicity: Unlike chemotherapy and radiation that target healthy and cancerous tissues, by use of toxic chemicals, Oncoprev™ utilizes the body's own immune system mechanisms to destroy cancer cells.
  • Broad Range of Efficacy: Equally effective for many types of cancer, including liver, colon, and breast. Competing treatments that use antibody-based cancer therapies work for only one cancer type and/or a small subset of patients with that specific cancer.
  • Diagnostic and Prognostic Applications: The ability to determine the location and extent of spread of cancer, and diagnose the disease in its earliest stages. No products exist today that can identify location and extent with such definitive accuracy.